|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001175,
umls-concept:C0011065,
umls-concept:C0020196,
umls-concept:C0021760,
umls-concept:C0035647,
umls-concept:C0060323,
umls-concept:C0205217,
umls-concept:C0332281,
umls-concept:C0441889,
umls-concept:C0449435,
umls-concept:C1413716,
umls-concept:C1704686,
umls-concept:C1963724
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2011-5-19
|
|
pubmed:abstractText |
Substantial morbidity occurs during the first year of antiretroviral therapy (ART) in persons with advanced human immunodeficiency virus (HIV) disease despite HIV suppression. Biomarkers may identify high-risk groups.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Retroviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Fibrinogen Degradation...,
http://linkedlifedata.com/resource/pubmed/chemical/Hyaluronic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/IL6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/fibrin fragment D
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1537-6613
|
|
pubmed:author |
pubmed-author:BakerJason VJV,
pubmed-author:BohjanenPaul RPR,
pubmed-author:BoulwareDavid RDR,
pubmed-author:FrenchMartyn AMA,
pubmed-author:HullsiekKatherine HupplerKH,
pubmed-author:INSIGHT Study Group,
pubmed-author:NeatonJames DJD,
pubmed-author:NovakRichard MRM,
pubmed-author:PuronenCamille ECE,
pubmed-author:RupertAdamA,
pubmed-author:SeretiIriniI
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
203
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1637-46
|
|
pubmed:meshHeading |
pubmed-meshheading:21592994-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:21592994-Adult,
pubmed-meshheading:21592994-Anti-Retroviral Agents,
pubmed-meshheading:21592994-Biological Markers,
pubmed-meshheading:21592994-C-Reactive Protein,
pubmed-meshheading:21592994-Case-Control Studies,
pubmed-meshheading:21592994-Disease Progression,
pubmed-meshheading:21592994-Female,
pubmed-meshheading:21592994-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:21592994-HIV Infections,
pubmed-meshheading:21592994-Humans,
pubmed-meshheading:21592994-Hyaluronic Acid,
pubmed-meshheading:21592994-Immune Reconstitution Inflammatory Syndrome,
pubmed-meshheading:21592994-Interleukin-6,
pubmed-meshheading:21592994-Male,
pubmed-meshheading:21592994-Middle Aged,
pubmed-meshheading:21592994-Morbidity,
pubmed-meshheading:21592994-RNA, Viral,
pubmed-meshheading:21592994-Risk Factors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
|
|
pubmed:affiliation |
University of Minnesota, Minneapolis, Minnesota, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|
